[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Cidara Therapeutics, Inc. (CDTX)
Merck is acquiring Cidara Therapeutics for $XXX billion, driving significant social media buzz and a surge in stock price. This acquisition is bolstered by a BARDA award and FDA Breakthrough Therapy Designation for CD388.
About Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. is a biotechnology company focused on developing novel therapeutics, particularly for influenza.
Cidara Therapeutics, Inc. uses the ticker $CDTX for trading. Listed in the Stocks category.
Insights
- Cidara Therapeutics, Inc. (CDTX) social dominance is up XXXXXX% from the previous week.
- Cidara Therapeutics, Inc. (CDTX) engagements is up 3434.98% from the previous X months.
- Cidara Therapeutics, Inc. (CDTX) posts created is up XXXXXX% from the previous month.
- Cidara Therapeutics, Inc. Price hit a 52-Week high of $XXXXXX for the hour
- Cidara Therapeutics, Inc. Price hit an all time of $XXXXXX for the hour
Price: $XXXXXX
Price 24-Hour Time-Series Raw Data
The stock price has surged dramatically, driven by the confirmation of a $XXX billion acquisition by Merck, alongside a BARDA award, FDA Breakthrough Therapy Designation, and analyst upgrades, amplifying upward trends due to increased social media discussions and engagements.
24-Hour: XXXX% 7-Day: -XXXX% 30-Day: XXXXXX%
1-Year High: $XXX on 2025-12-03
1-Year Low: $XXXXX on 2025-04-04
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
Cidara Therapeutics, Inc. (CDTX) is currently AltRank #603 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +376
X Month: XXX +385
1-Year High: XXXXX on 2025-11-10
1-Year Low: XX on 2025-11-19
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -XX
1-Year High: XX on 2025-11-14
1-Year Low: XX on 2025-11-21
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXXX +1,016%
X Month: XXXXXXXXX +822%
X Months: XXXXXXXXX +3,435%
X Year: XXXXXXXXX +1,514%
1-Year High: XXXXXXXXX on 2025-11-14
1-Year Low: X on 2025-02-05
Engagements by network (24h): Reddit: XX X: XXXXX YouTube: X
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX +586%
X Months: XXXXXX +17,889%
1-Year High: XXXXX on 2025-06-24
1-Year Low: X on 2025-01-26
Mentions by network (24h): Reddit: XX X: XXX YouTube: X
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Cidara Therapeutics, Inc. (CDTX) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XXX -XX%
X Month: XXXXX +742%
X Months: XXXXX +17,600%
1-Year High: XXXXX on 2025-06-23
1-Year Low: X on 2025-01-26
The most influential creators that mention Cidara Therapeutics, Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @seedy19tron | X | XXXXX | X | XXXXX |
| @SuperDuperInvst | X | XXXXXX | X | XXX |
| @dbr_says | X | XXXXX | X | XXX |
| @aipatternlab | X | XXXXX | XX | XXX |
| @A_May_MD | X | XXXXXX | X | XXX |
| @scottlacombe77 | X | XX | X | XX |
| @BiopharmIQ | X | XXXXXX | X | XX |
| @linhnguyen64143 | X | XX | X | XX |
| @PrimeTrading_ | X | XXXXXX | X | XX |
| @marketwirenews | XX | XXXXXX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-01-14
1-Year Low: XX% on 2025-01-28
Most Supportive Themes:
- BARDA Award: (8%) Cidara Therapeutics received a substantial BARDA award to support manufacturing and clinical development of CD388.
- FDA Breakthrough Therapy Designation: (7%) The FDA granted Breakthrough Therapy Designation to CD388 for the prevention of seasonal influenza.
- Analyst Ratings: (10%) JP Morgan initiated coverage on Cidara Therapeutics with an Overweight rating and a $XXX price target.
Most Critical Themes:
- Valuation Concerns: (5%) Some analysts express concern about the current valuation of $CDTX, with one noting it seems expensive at a $XXX billion market cap and that Phase X trials could fail.
Social Dominance: XXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.015%
X Month: XXXXX% +0.0068%
X Months: XXXXX% +0.017%
X Year: XXXXX% +0.013%
1-Year High: XXXXX% on 2025-06-24
1-Year Low: XXXXXX% on 2025-04-09
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-11-23
1-Year Low: XXXXXXX% on 2025-12-11
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$0.10%
X Month: $XXXXXXXXXXXXX +$104%
1-Year High: $XXXXXXXXXXXXX on 2025-12-03
1-Year Low: $XXXXXXXXXXXXX on 2025-11-05
Top Cidara Therapeutics, Inc. Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"52 Week Gainers - US Stocks by Yahoo Finance: $QMMM QMMM $RGC Regencell Bioscience $TAWNF Thai Airways Public $ABVX ABIVAX Socit Anonyme $CDTX Cidara Therapeutics $DSVSF Discovery Silver $TMC TMC the metals company $ONDS Ondas $CELC Celcuity $QBTS D-Wave Quantum $TERN Terns Pharmaceuticals $SNDK Sandisk $OKLO Oklo $BMNR Bitmine Immersion $COGT Cogent Biosciences #StockInFocus"
X Link @aipatternlab 2025-12-11T18:00Z 4462 followers, XXX engagements
"$CADL DM X join us👇🏆 $TGL $RETO $AXIL $BTTC $PETS $DHIL $BBGI $BDRX $ASPC $PLAB $CHOW $AFJK $SMX $SOXS $BQ $JZXN $GEMI $BEAT $IRBT $ONDS $BYND $ASST $TSLA $AAPL $META $MSFT $GOOGL $PLTR $NVDA $DJT $BTC $ETH $XRP $DOGE $SPY $QQQ $SPY $AMC $GME $OPEN $POM $NXDR $GRAN $IHRT $YGMZ"
X Link @dbr_says 2025-12-11T16:18Z 1804 followers, XXX engagements
"$ABVX now at a $10.72B market cap I reiterate if youre not in now it is not cheap but the premium is likely still solid especially after seeing BP bidding war for $CDTX Would not recommend starting a large position and chasing here on hopes of buyout. Its biotech after all anything can happen"
X Link @MitchMartan98 2025-12-11T16:11Z 6402 followers, 3581 engagements
"Merck & J&J Announce Major Biotech Acquisitions to Expand Drug Pipelines#business"
YouTube Link @k 2025-12-11T07:00Z X followers, X engagements